Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Ruxolitinib”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT06616155
What this trial is testing

Ruxolitinib and Enzalutamide for the Treatment of Metastatic Castration-Resistant Prostate Cancer

Who this might be right for
Castration-Resistant Prostate CarcinomaMetastatic Prostate AdenocarcinomaStage IVB Prostate Cancer AJCC v8
University of Michigan Rogel Cancer Center 20
Early research (Phase 1)Looking for participantsNCT03874052
What this trial is testing

Ruxolitinib in Combination With Venetoclax With and Without Azacitidine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia Arising From Previous Myelodysplastic SyndromeRecurrent Acute Myeloid LeukemiaRecurrent Secondary Acute Myeloid Leukemia+2 more
Jennifer Saultz 51
Large-scale testing (Phase 3)Study completedNCT04472598
What this trial is testing

Study of Oral Navitoclax Tablet In Combination With Oral Ruxolitinib Tablet When Compared With Oral Ruxolitinib Tablet To Assess Change In Spleen Volume In Adult Participants With Myelofibrosis

Who this might be right for
Myelofibrosis (MF)
AbbVie 252
Not applicableStudy completedNCT05665192
What this trial is testing

Assess Real-World Patient-Reported Outcomes With Fedratinib for Myelofibrosis Post-Ruxolitinib

Who this might be right for
Myelofibrosis
Bristol-Myers Squibb 150
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07796620
What this trial is testing

Sirolimus+Ruxolitinib+Mycophenolate Mofetil for Prophylaxis of aGVHD in Patients Receiving Haplo-HSCT Who Are Intolerant to CNI

Who this might be right for
Acute LeukemiaMyelodysplastic SyndromesSevere Aplastic Anemia (SAA)
Peking University People's Hospital 40
Post-approval studies (Phase 4)Ended earlyNCT05696392
What this trial is testing

The Purpose of This Study is to Evaluate the Effects of Ruxolitinib Cream on Adults With Atopic Dermatitis Experiencing Sleep Disturbance.

Who this might be right for
Atopic Dermatitis
Incyte Corporation 47
Large-scale testing (Phase 3)Not Yet RecruitingNCT07568535
What this trial is testing

A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase III Trial of Remestemcel-L-rknd Added to Ruxolitinib for Grade III-IV Steroid-Refractory Acute Graft-Versus-Host Disease

Who this might be right for
GVHD - Graft-Versus-Host Disease
Mesoblast, Ltd. 180
Testing effectiveness (Phase 2)Study completedNCT01375140
What this trial is testing

Ruxolitinib and Lenalidomide for Patients With Myelofibrosis

Who this might be right for
Myeloproliferative Diseases
M.D. Anderson Cancer Center 31
Early research (Phase 1)Active Not RecruitingNCT04041050
What this trial is testing

A Study Evaluating Safety and Tolerability, and Pharmacokinetics of Navitoclax Monotherapy and in Combination With Ruxolitinib in Participants With Myeloproliferative Neoplasm

Who this might be right for
Myeloproliferative Neoplasm
AbbVie 85
Testing effectiveness (Phase 2)Looking for participantsNCT07252050
What this trial is testing

Ruxolitinib-Enhanced Haplo HCT for Children and Young Adults With Sickle Cell Disease

Who this might be right for
Sickle Cell DiseaseHematopoetic Stem Cell TransplantHaploidentical Hematopoietic Stem Cell Transplant+2 more
Arkansas Children's Hospital Research Institute 24
Testing effectiveness (Phase 2)Study completedNCT01787552
What this trial is testing

A Phase Ib/II Dose-finding Study to Assess the Safety and Efficacy of LDE225 + INC424 in Patients With MF

Who this might be right for
Primary MyelofibrosisThrombocytosisEssential Thrombocythemia+7 more
Novartis Pharmaceuticals 50
Not applicableActive Not RecruitingNCT05548062
What this trial is testing

Study to Identify and Describe Predictive Factors for Thromboembolic Events in Patients With High-risk Polycythemia Vera

Who this might be right for
Polycythemia Vera
Novartis Pharmaceuticals 242
Early research (Phase 1)Study completedNCT02917096
What this trial is testing

Ruxolitinib Phosphate and Chemotherapy Given Before and After Reduced Intensity Donor Stem Cell Transplant in Treating Patients With Myelofibrosis

Who this might be right for
Primary MyelofibrosisSecondary Myelofibrosis
City of Hope Medical Center 18
Early research (Phase 1)Active Not RecruitingNCT03120624
What this trial is testing

VSV-hIFNbeta-NIS With or Without Ruxolitinib Phosphate in Treating Stage IV or Recurrent Endometrial Cancer

Who this might be right for
Metastatic Endometrial CarcinomaRecurrent Endometrial AdenocarcinomaRecurrent Endometrial Carcinoma+7 more
Mayo Clinic 34
Testing effectiveness (Phase 2)Looking for participantsNCT05762640
What this trial is testing

Ruxolitinib as First Line Treatment in Primary Haemophagocytic Lymphohistiocytosis (R-HLH)

Who this might be right for
Haemophagocytic Lymphohistiocytosis
Assistance Publique - Hôpitaux de Paris 20
Not applicableStudy completedNCT05052385
What this trial is testing

ECP Combination Study

Who this might be right for
Steroid Refractory GVHD
European Society for Blood and Marrow Transplantation 319
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07643025
What this trial is testing

Belumosudil With Ruxolitnib as Second Line Therapy for Chronic Graft Versus Host Disease (cGvHD) After Steroid Failure

Who this might be right for
cGVHD
Dennis Kim 63
Post-approval studies (Phase 4)UnknownNCT04999878
What this trial is testing

A Prospective Clinical Study of Ruxolitinib and Etoposide Combined With DDGP Regimen (RUE-DDGP) in Induction Therapy of T/NK Cell Lymphoma-associated Hemophagocytic Syndrome.

Who this might be right for
Hemophagocytic SyndromeT/NK-Cell Lymphoma
Zhengzhou University 30
Testing effectiveness (Phase 2)Active Not RecruitingNCT02577926
What this trial is testing

The Ruxo-BEAT Trial in Patients With High-risk Polycythemia Vera or High-risk Essential Thrombocythemia

Who this might be right for
Polycythemia Vera (PV)Essential Thrombocythemia (ET)
RWTH Aachen University 207
Not applicableLooking for participantsNCT06516406
What this trial is testing

Ruxolitinib in Primary Myelofibrosis and Secondary to Essential Thrombocythemia or Polycythemia Vera

Who this might be right for
MyelofibrosisPrimary MyelofibrosisSecondary Myelofibrosis
IRCCS Azienda Ospedaliero-Universitaria di Bologna 1,055
Next Page